AUM Biosciences, a Singapore-headquartered biotech company focused on precision oncology therapeutics, allotted shares worth $11.8 million earlier this week. Everlife Holdings, a market access and distribution company in India and Southeast Asia, received the bulk of the new shares. AUM Biosciences … Read More